elemene
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
1
Earliest trial started Sep 20, 2020 (NCT04401059)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Focal adhesion kinase 1INHIBITOR
PTK2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05842746 | Phase 2 | May 31, 2023 | Chinese Academy of Medical Sciences |
| NCT04674527 | Phase 2 | Jun 1, 2021 | Hangzhou Normal University, Zhejiang University |
| NCT04401059 | Phase 4 | Sep 20, 2020 | Chinese Academy of Medical Sciences, Hangzhou Normal University, LinkDoc Technology (Beijing) Co. Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 1 | 2 | 2020 |
| Hangzhou Normal University | Academic/Hospital | 2 | 1 | 2 | 2020 |
| LinkDoc Technology (Beijing) Co. Ltd. | For profit | 1 | 0 | 1 | 2020 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2021 |
4 organizations
Page 1 / 1